F Sarepta Therapeutics, Inc. Transaction History
F
- $2.07 Billion
- Q1 2025
A detailed history of F transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, F holds 17,983 shares of SRPT stock, worth $676,160. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,983
Previous 16,924
6.26%
Holding current value
$676,160
Previous $2.06 Million
44.24%
% of portfolio
0.06%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
506Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$388 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$341 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$340 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$153 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$127 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.29B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...